The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral SM-88 plus MPS, an effective yet less toxic treatment option in second-line advanced pancreatic cancer? Final phase II/III study results.
 
Marcus Smith Noel
Consulting or Advisory Role - Celgene; Ipsen; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Daiichi Sankyo/Astra Zeneca; Taiho Pharmaceutical
 
Steve Wong
No Relationships to Disclose
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Amgen; Cigna; Johnson & Johnson; McKesson; Thermo Fisher Scientific
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Abbvie; Celgene; FibroGen; Ipsen; Merck; NGM Biopharmaceuticals; NovoCure; Tyme
 
Harry Staszewski
No Relationships to Disclose
 
Dae Won Kim
Research Funding - Bold Therapeutics
 
Marion L. Hartley
No Relationships to Disclose
 
Maria Loushin
Employment - Tyme
Stock and Other Ownership Interests - Tyme
Travel, Accommodations, Expenses - Tyme
 
Shabnam Stanicky
Employment - Click Therapeutics (I)
Leadership - Click Therapeutics (I)
Stock and Other Ownership Interests - Tyme
 
Justin Lau
Employment - Tyme
Stock and Other Ownership Interests - Tyme
 
Semmie Kim
Employment - Tyme
Stock and Other Ownership Interests - Tyme
 
Jan Van Tornout
Employment - Tyme
Stock and Other Ownership Interests - Bristol-Myers Squibb; Lilly; Merck; Novartis; Sanofi; Tyme
Honoraria - Tyme
Consulting or Advisory Role - Tyme
Travel, Accommodations, Expenses - Tyme
 
Philip Agop Philip
Honoraria - Array BioPharma; AstraZeneca; Bayer; Blueprint Medicines; Celgene; Ipsen; Merck; SynCoreBio; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Ipsen; Merck; SynCoreBio; Taiho Pharmaceutical; TriSalus Life Sciences
Speakers' Bureau - Bayer; Celgene; Incyte; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); merus (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); tyme (Inst); TYME (Inst)
Travel, Accommodations, Expenses - Abbvie; celgene; Rafael Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Caris MPI; Rafael Pharmaceuticals
 
Vincent Chung
Consulting or Advisory Role - Apeiron Biologics; Gritstone Bio; Ipsen; Westwood Bioscience
Speakers' Bureau - Celgene; Ipsen
Research Funding - Merck; Roche
 
Allyson J. Ocean
Consulting or Advisory Role - Celgene; Tyme
Speakers' Bureau - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Andrea wang-gillam
Employment - Jacobio
Stock and Other Ownership Interests - Jacobio
Consulting or Advisory Role - AstraZeneca; Bayer; Inxmed; Merck
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Gossamer Bio (Inst); Hutchison MediPharma (Inst); Lilly (Inst); Merck (Inst); pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)